USD 23.25
(-3.0%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 | -131.77 Million USD | 25.36% |
2023 | -176.55 Million USD | -51.14% |
2022 | -116.81 Million USD | -355.05% |
2021 | -25.67 Million USD | -114.09% |
2020 | -11.99 Million USD | -26.31% |
2019 | -9.49 Million USD | 34.76% |
2018 | -14.55 Million USD | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q4 | -29.58 Million USD | 7.67% |
2024 FY | -133.37 Million USD | 24.46% |
2024 Q3 | -32.04 Million USD | 13.29% |
2024 Q1 | -37.9 Million USD | 4.8% |
2024 Q2 | -36.95 Million USD | 2.5% |
2023 Q3 | -39.81 Million USD | 14.08% |
2023 Q2 | -46.33 Million USD | 8.42% |
2023 FY | -176.55 Million USD | -51.14% |
2023 Q1 | -50.59 Million USD | -8.53% |
2023 Q4 | -39.81 Million USD | -0.01% |
2022 Q2 | -23.8 Million USD | -123.49% |
2022 Q1 | -10.65 Million USD | -28.64% |
2022 Q3 | -35.74 Million USD | -50.12% |
2022 FY | -116.81 Million USD | -355.05% |
2022 Q4 | -46.61 Million USD | -30.43% |
2021 Q2 | -6.31 Million USD | -27.06% |
2021 Q1 | -4.96 Million USD | -6.29% |
2021 Q3 | -6.11 Million USD | 3.11% |
2021 Q4 | -8.28 Million USD | -35.44% |
2021 FY | -25.67 Million USD | -114.09% |
2020 FY | -11.99 Million USD | -26.31% |
2020 Q3 | -2.23 Million USD | 46.12% |
2020 Q4 | -4.67 Million USD | -109.41% |
2020 Q2 | -4.14 Million USD | 2.68% |
2020 Q1 | -4.25 Million USD | -28.98% |
2019 FY | -9.49 Million USD | 34.76% |
2019 Q4 | -3.29 Million USD | -8.65% |
2019 Q1 | -1.9 Million USD | 0.0% |
2019 Q2 | -1.24 Million USD | 34.61% |
2019 Q3 | -3.03 Million USD | -143.1% |
2018 FY | -14.55 Million USD | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
American Well Corporation | -692.14 Million USD | 80.962% |
Doximity, Inc. | 163.87 Million USD | 180.409% |
Evolent Health, Inc. | -71.21 Million USD | -85.046% |
MultiPlan Corporation | 173.4 Million USD | 175.992% |
Teladoc Health, Inc. | -248.55 Million USD | 46.984% |
Veeva Systems Inc. | 429.33 Million USD | 130.692% |